-$0.08 EPS Expected for Neptune Wellness Solutions Inc (NASDAQ:NEPT) This Quarter

Equities research analysts forecast that Neptune Wellness Solutions Inc (NASDAQ:NEPT) (TSE:NTB) will report earnings per share (EPS) of ($0.08) for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for Neptune Wellness Solutions’ earnings. Neptune Wellness Solutions posted earnings per share of ($0.12) during the same quarter last year, which suggests a positive year over year growth rate of 33.3%. The company is scheduled to announce its next earnings report on Monday, February 21st.

On average, analysts expect that Neptune Wellness Solutions will report full-year earnings of ($0.30) per share for the current fiscal year. For the next financial year, analysts forecast that the company will report earnings of ($0.12) per share. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of analysts that cover Neptune Wellness Solutions.

Neptune Wellness Solutions (NASDAQ:NEPT) (TSE:NTB) last issued its earnings results on Monday, November 15th. The biotechnology company reported ($0.09) EPS for the quarter, hitting analysts’ consensus estimates of ($0.09). Neptune Wellness Solutions had a negative return on equity of 74.86% and a negative net margin of 344.98%. The firm had revenue of $12.50 million for the quarter, compared to the consensus estimate of $10.99 million.

NEPT has been the topic of a number of recent research reports. Zacks Investment Research upgraded Neptune Wellness Solutions from a “sell” rating to a “hold” rating in a research note on Wednesday, September 22nd. Desjardins lowered their target price on Neptune Wellness Solutions from C$1.00 to C$0.75 and set a “hold” rating on the stock in a research note on Wednesday, November 17th.

A number of hedge funds have recently modified their holdings of the business. Morgan Stanley boosted its position in Neptune Wellness Solutions by 256.1% during the third quarter. Morgan Stanley now owns 503,122 shares of the biotechnology company’s stock worth $304,000 after purchasing an additional 361,853 shares in the last quarter. Penserra Capital Management LLC raised its holdings in shares of Neptune Wellness Solutions by 53.2% during the third quarter. Penserra Capital Management LLC now owns 2,403,104 shares of the biotechnology company’s stock valued at $1,452,000 after acquiring an additional 834,504 shares during the last quarter. Natixis acquired a new position in shares of Neptune Wellness Solutions during the third quarter valued at approximately $69,000. Goldman Sachs Group Inc. raised its holdings in shares of Neptune Wellness Solutions by 2,047.4% during the third quarter. Goldman Sachs Group Inc. now owns 3,005,884 shares of the biotechnology company’s stock valued at $1,817,000 after acquiring an additional 2,865,906 shares during the last quarter. Finally, Commonwealth Equity Services LLC raised its holdings in shares of Neptune Wellness Solutions by 169.2% during the third quarter. Commonwealth Equity Services LLC now owns 1,151,121 shares of the biotechnology company’s stock valued at $695,000 after acquiring an additional 723,480 shares during the last quarter. Institutional investors own 12.43% of the company’s stock.

Shares of NEPT traded down $0.02 during mid-day trading on Friday, reaching $0.50. The company had a trading volume of 646,684 shares, compared to its average volume of 3,134,699. Neptune Wellness Solutions has a 52-week low of $0.47 and a 52-week high of $3.60. The company has a quick ratio of 2.18, a current ratio of 3.05 and a debt-to-equity ratio of 0.09. The stock has a market capitalization of $83.66 million, a P/E ratio of -0.49 and a beta of 2.27. The stock has a 50 day moving average of $0.54 and a two-hundred day moving average of $0.81.

About Neptune Wellness Solutions

Neptune Wellness Solutions Inc, a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils.

Featured Article: What are high-yield dividend stocks?

Get a free copy of the Zacks research report on Neptune Wellness Solutions (NEPT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Neptune Wellness Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Wellness Solutions and related companies with MarketBeat.com's FREE daily email newsletter.